SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
BioCube, Inc. (BICB) .
本页证实的标准:
- VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。
SharesGrow 综合评分： 8/100 其中 0/7 项标准通过。
SharesGrow 7-Criteria Score
✗
健康
0/100
Debt-to-Equity & liquidity
→ Health
估值概览 — BICB
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$0.00
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2007 |
$0.00 |
$236.06K |
$-8.06K |
-3.4% |
| 2008 |
$-3.71 |
$12.31M |
$-5.54M |
-45.1% |
| 2009 |
$-2.33 |
$44.55M |
$-3.98M |
-8.9% |
| 2011 |
$-0.04 |
$0.00 |
$-1.03M |
- |
| 2012 |
$0.00 |
$0.00 |
$-91.55K |
- |
| 2013 |
$-0.02 |
$0.00 |
$-764.5K |
- |
| 2019 |
$0.00 |
$0.00 |
$0.00 |
- |
| 2020 |
$0.00 |
$0.00 |
$0.00 |
- |
| 2021 |
$0.00 |
$0.00 |
$0.00 |
- |
| 2022 |
$0.00 |
$0.00 |
$-39.35K |
- |
